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Abstract
Background: Postconditioning (PostC) inhibits myocardial apoptosis after ischemia-reperfusion (I/R) injury. The
JAK2-STAT3 pathway has anti-apoptotic effects and plays an essential role in the late protection of preconditioning.
Our aim was to investigate the anti-apoptotic effect of PostC after prolonged reperfusion and the role of the JAK2-
STAT3 pathway in the anti-apoptotic effect of PostC.
Methods: Wistar rats were subjected to 30 minutes ischemia and 2 or 24 hours (h) reperfusion, with or without
PostC (three cycles of 10 seconds reperfusion and 10 seconds reocclusion at the onset of reperfusion). Separate
groups of rats were treated with a JAK2 inhibitor (AG490) or a PI3K inhibitor (wortmannin) 5 minutes before PostC.
Immunohistochemistry was used to analyze Bcl-2 protein levels after reperfusion. mRNA levels of Bcl-2 were
detected by qRT-PCR. TTC staining was used to detect myocardial infarction size. Myocardial apoptosis was
evaluated by TUNEL staining. Western-blot was used to detect p-STAT3 and p-Akt levels after reperfusion.
Results: There was more myocardial apoptosis at 24 h vs 2 h after reperfusion in all groups. PostC significantly
reduced myocardial apoptosis and elevated Bcl-2 levels at both 2 and 24 hours after reperfusion. PostC increased
p-STAT3 and p-Akt levels after reperfusion. Administration of AG490 reduced p-STAT3 and p-Akt levels and
attenuated the anti-apoptotic effect of PostC. Wortmannin also reduced p-Akt levels and attenuated the anti-
apoptotic effect of PostC but had no effect on p-STAT3 levels. AG490 abrogated the up-regulation of Bcl-2 by
PostC.
Conclusion: PostC may reduce myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2
pathway. As a downstream target of JAK2 signaling, activation of PI3K/Akt pathway may be necessary in the
protection of PostC.
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Background
Postconditioning (PostC), defined as transient periods of
ischemia and reperfusion at the onset of reperfusion, has
been shown to be protective against myocardial ischemia-
reperfusion (I/R) injury in multiple species [1]. Recent
studies reported that the cardioprotective effects of PostC
persisted after prolonged reperfusion [2,3]. Cardiomyocyte
apoptosis is one of the major mechanisms underlying I/R
injury. The progressive loss of cardiomyocytes due to
apoptosis plays a critical role in cardiac dysfunction after
acute myocardial infarction. Previous studies have
reported that PostC inhibits apoptosis in both in vivo and
in vitro models [4,5]. However, the anti-apoptotic effect of
PostC after prolonged reperfusion has not yet been well
defined.
The Janus kinase (JAK)-signal transducers and activators
of transcription (STAT) pathway is an evolutionary con-
served signaling network involved in a wide range of dis-
tinct cellular processes, including inflammation, apoptosis,
cell-cycle control and development. As a part of SAFE
(Survivor Activating Factor Enhancement) pathway, the
* Correspondence: minxinw@yahoo.com
† Contributed equally
1Department of Cardiovascular Surgery, Tianjin Medical University General
Hospital, Tianjin, P. R. China
Full list of author information is available at the end of the article
Tian et al. Journal of Biomedical Science 2011, 18:53
http://www.jbiomedsci.com/content/18/1/53
© 2011 Tian et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.JAK2-STAT3 pathway has anti-apoptotic effects and plays
essential roles in postconditioning and the late protection
of preconditioning [6-8]. However, the role of the JAK2-
STAT3 pathway in the anti-apoptotic effects of PostC is
not yet fully understood. The present study was designed
to investigate the anti-apoptotic effect of PostC after pro-
longed reperfusion and to define the role of the JAK2-
STAT3 pathway in this.
Methods
All animals were obtained from the Chinese People’s Lib-
eration Army Academy of Military Medical Sciences. The
experimental protocol was approved by the Tianjin Med-
ical University Animal Care and Use Committee. Male
Wistar rats weighing 240 to 280 g were anesthetized with
sodium pentobarbital (40-50 mg/kg, intraperitoneal) and
ventilated with oxygen-enriched room air using a rodent
ventilator. The left carotid artery was cannulated for
monitoring arterial pressure and electrocardiogram
(ECG) leads were placed to record heart rate. The chest
was opened by a left thoracotomy in the fifth intercostal
space. After pericardiotomy, a 6-0 prolene ligature was
placed under the left coronary artery (LCA) where it
emerges from beneath the left atrial appendage and the
ends were threaded through a small plastic tube to form
a snare for reversible LCA occlusion. Complete LCA
occlusion was confirmed by observing cyanosis of the
myocardium as well as ST-segment deviation.
Experimental protocol
Rats were randomized into five groups, as shown in Fig-
ure 1:
(1) sham group - the ligature was placed under the
LCA without occlusion;
(2) I/R group - no interventions were applied either
before or after LCA occlusion;
(3) PostC group - three cycles of 10 s of reperfusion
and 10 s of reocclusion immediately at the onset of
reperfusion;
(4) PostC+Ag490 group - the JAK2 inhibitor AG 490
(Sigma-Aldrich, St. Louis, MO, dissolved in 0.1%
DMSO solution, 3 mg/Kg, iv) was administered 5
min before PostC;
(5) PostC+wortmannin group - the PI3K inhibitor
wortmannin (Sigma-Aldrich, St. Louis, MO, dis-
solved in 0.1% DMSO solution, 1.5 mg/Kg, ip) was
administered 5 min before PostC.
Other two control groups, treating rats with Ag490 or
wortmannin alone without PostC, were designed to eval-
uate the effects of Ag490 and wortmannin alone in I/R
group. The doses of AG490 (3 mg/Kg,iv) and wortman-
nin (1.5 mg/Kg, ip) were according to previous study
[9]. Additional rats from the sham and PostC groups
were treated with 0.1% DMSO to detect any indepen-
dent effects of the DMSO vehicle. Myocardial biopsies
from the sham group were obtained at 20 min, 2.5 h or
24 h after thoracotomy (n = 4 at each time point). The
other groups were subjected to 30 min of LCA occlu-
sion followed by 10 min (n = 8, for signaling pathway
detections), 2 h (n = 8, for TUNEL and Bcl-2 detec-
tions) or 24 h (n = 8, for TUNEL and Bcl-2 detections)
of reperfusion. Myocardial biopsies were taken at the
end of the experiment. The PostC protocol was per-
formed with three cycles of 10 s of reperfusion and 10 s
of reocclusion immediately at the onset of reperfusion
as reported previously [4].
Myocardial infarction size analysis
After reperfusion, the LCA was re-ligated at its original
site. 2 ml of 2% evans blue was injected into the inferior
vena cava to define the area at risk (AAR). The ventri-
cles of the hearts were sliced transversely into 2-mm
thick slices. The slices were incubated in 1% triphenylte-
trazolium chloride (TTC, sigma) at 37°C for 15 min to
identify the infarction size (IS). AAR and IS were deter-
mined by computerized planimetry using ImageJ soft-
ware. AAR was expressed as a percentage of the left
ventricle and IS was expressed as a percentage of the
AAR.
TUNEL (Terminal Doxynucleotidyl Transferase-mediated
dUTP-X Nick End Labeling) staining
The histochemical detection of apoptotic cells was per-
formed as previously reported [4]. The tissue blocks
were fixed in 4% paraformaldehyde and incubated with
proteinase K. Fragments of DNA in the tissue sections
were analyzed using a TUNEL detection kit (Promega
Figure 1 Experimental groups and their protocols.R a t sw e r e
randomly divided into five groups as showed in the figure.
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images of 10 separate fields were captured randomly
and digitized. The cells with clear nuclear labeling were
defined as TUNEL-positive cells. The apoptotic index
was calculated as the number of TUNEL-positive cells/
total number of myocytes × 100.
Immunohistochemistry
Transmural LV samples were embedded in paraffin and
cut into 5μm sections. Detection of Bcl-2 expression
was performed as described previously [10]. Tissue sec-
tions were exposed overnight to rabbit polyclonal anti-
bcl-2 antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) at 4°C, washed in PBS and then incubated with bio-
t i n y l a t e dg o a ta n t i r a b b i tI g Gf o r6 0m i na t3 7 ° C .A f t e r
two washing steps, sections were exposed to streptavi-
din-horseradish-peroxidase complex for 30 min at 37°C,
and then visualized with 3,3’-diaminobenzidine,
embedded in glycerol gelatin and coverslips applied.
Images were captured digitally and analyzed using
Image-Pro Plus version 6.0 (Media Cybernetics, Inc,
Bethesda, MD). The result was expressed as the ratio of
positive to negative staining area.
Western-blot analysis
Transmural LV samples were obtained after 10 min of
reperfusion. Western blotting was performed as
described previously (5). In brief, freshly frozen myo-
cardial tissue samples were homogenized in RIPA buf-
fer. Total protein was separated by 10% SDS-PAGE
and transferred to nitrocellulose membranes. Mem-
branes were exposed to p-Akt, Akt, p-STAT3(Tyr705)
or STAT3 antibody(Cell Signaling Technology, Beverly
MA), and subsequently incubated with a chemilumi-
nescence substrate and exposed to radiographic film.
The images were captured digitally and the density at
specific molecular weights was measured using Gel-Pro
analyzer version 3.0 (Media Cybernetics, Inc, Bethesda,
MD).
Quantitative reverse transcriptase-polymerase chain
reaction
Bcl-2 mRNA levels were determined by quantitative
reverse transcriptase-polymerase chain reaction (qRT-
PCR). For extraction of total RNA the RNeasy Mini Kit
(QIAGEN China Co., Ltd, Shanghai) was used according
to the manufacturer’s instructions. cDNAs were synthe-
sized using RevertAid™ First Strand cDNA Synthesis
Kit(Fermentas China Co., Ltd. Shenzhen). qPCR was
performed with Maxima
® SYBR Green qPCR Master
Mix, ROX Solution provided(Fermentas China Co., Ltd.
Shenzhen). Fluorescent signals were normalized to an
internal reference, and the threshold cycle (Ct) was set
within the exponential phase of the PCR. The relative
gene expression was calculated by comparing cycle
times for each target PCR. The target PCR Ct values
were normalized by subtracting the GAPDH Ct value,
which provided the ΔCt value. mRNA levels were quan-
tified with the 2
(-ΔΔct) relative quantification method.
T h ef o l l o w i n gp r i m e r sw e r eu s e df o rd e t e c t i o n :B c l - 2
Table 1 Hemodynamic Data
Measurements Baseline Ischemia 2 h after reperfusion 24 h after reperfusion
Groups HR
(Beat/min)
MABP (mmHg) HR
(Beat/min)
MABP (mmHg) HR
(Beat/min)
MABP (mmHg) HR
(Beat/min)
MABP (mmHg)
Sham-10 m 381 ± 5 98 ± 3 382 ± 4 97 ± 3 - - -
Sham-2 h 373 ± 5 98 ± 4 380 ± 5 96 ± 3 379 ± 4 96 ± 2 - -
Sham-24 h 373 ± 3 97 ± 4 373 ± 3 96 ± 4 371 ± 3 97 ± 3 368 ± 4 95 ± 3
Control-10 m 376 ± 4 97 ± 4 382 ± 4 81 ± 2* - - - -
Control-2 h 373 ± 5 96 ± 3 379 ± 5 82 ± 3* 371 ± 5 96 ± 3 - -
Control-24 h 374 ± 5 99 ± 2 379 ± 5 81 ± 2* 378 ± 3 98 ± 3 373 ± 2 96 ± 3
Post-10 m 374 ± 4 96 ± 4 383 ± 4 82 ± 3* - - - -
Post-2 h 379 ± 4 95 ± 5 389 ± 4 81 ± 3* 381 ± 4 96 ± 4 - -
Post-24 h 375 ± 4 96 ± 4 383 ± 4 82 ± 2* 374 ± 4 96 ± 4 375 ± 3 94 ± 3
Post+Ag490-10 m 374 ± 5 97 ± 3 381 ± 4 81 ± 3* - - - -
Post+Ag490-2 h 381 ± 5 98 ± 2 383 ± 6 80 ± 2* 377 ± 5 96 ± 2 - -
Post+Ag490-24 h 379 ± 4 98 ± 2 382 ± 4 86 ± 3* 376 ± 5 93 ± 2 376 ± 4 95 ± 3
Post+wort-10 m 376 ± 6 97 ± 3 380 ± 6 79 ± 3* - - - -
Post+wort-2 h 377 ± 5 97 ± 3 386 ± 4 80 ± 3* 375 ± 4 96 ± 3 - -
Post+wort-24 h 373 ± 6 97 ± 2 380 ± 6 86 ± 2* 368 ± 5 97 ± 3 369 ± 3 95 ± 3
*p < 0.05 compared with baseline. HR = heart rate, MABP = mean artery blood pressure.
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CAGCCTCCGTTATCCT. GAPDH FW: ACTTTGT-
CAAGCTCATTTCCTG, RV: CTCTCTTCCTCTTG
TGCTCTTG.
Statistical analysis
All data are expressed as mean ± SEM and analyzed
using SPSS 15.0 (Chicago, IL). Independent samples t-
test and one-way ANOVA were used to compare data
with post hoc analysis using the Student-Newman-Keuls
correction. A p-value <0.05 was considered significant.
Results
Hemodynamic data (Table 1)
There were no baseline differences. After 30 min ische-
mia, mean arterial blood pressure decreased significantly
between the sham and intervention groups. No statisti-
cal differences were observed among all groups at both
2 and 24 hours after reperfusion.
Myocardial infarction after prolonged reperfusion
No myocardial infarction was found in sham group.
Area of risk was similar among all treatment groups.
Myocardial infarction area was increased between 2 and
24 hours after reperfusion in all intervention groups.
PostC significantly reduced myocardial infarction size
after reperfusion (Figure 2). Treatment with AG490 and
wortmannin alone had no effect on myocardial infarc-
tion after reperfusion in I/R group.
Myocardial apoptosis after prolonged reperfusion
There were no TUNEL-positive cells in the sham group.
There was more apoptosis at 24 h compared to 2 h
reperfusion in all intervention groups (Figure 3). PostC
significantly reduced myocardial apoptosis at 2 and 24 h
after reperfusion. Treating rats with AG490 or wort-
mannin significantly attenuated anti-apoptosis effects of
PostC. However, AG490 or wortmannin alone had no
effect on apoptosis index after reperfusion in I/R group.
Myocardial Bcl-2 levels
Both protein and mRNA levels of Bcl-2 were similar at
2 and 24 h in the control group. PostC elevated levels of
Bcl-2 after reperfusion, which increased between 2 and
24 h after reperfusion. The JAK2 inhibitor AG490
decreased Bcl-2 levels after reperfusion. The PI3K inhi-
bitor wortmannin had no effects on Bcl-2 levels (Figure
4, 5).
Correlation between JAK2-STAT3 and PI3K/Akt signaling
pathways in PostC
PostC significant increased the expression of p-STAT3
and p-Akt. Administration of AG490 before PostC
reduced p-STAT3 and p-Akt levels and attenuated the
cardioprotection effect of PostC. Wortmannin also
reduced p-Akt levels and attenuated the cardioprotec-
tion effect of PostC but had no effect on p-STAT3 levels
(Figures 6 and 7).
Discussion
The present study demonstrated that apoptosis follow-
ing I/R injury increases after prolonged reperfusion. The
prolonged anti-apoptotic effect of PostC may be related
to elevation of Bcl-2 24 h after reperfusion which is
regulated by the JAK2-STAT3 pathway. PI3K/Akt path-
way, regulated by JAK2 signaling, may be necessary in
the protection of PostC.
Previous studies have shown that oxidative stress, Ca
2+
overload, pH paradox and inflammation during early
reperfusion are the major mediators of lethal injury
which indicates that this period is important in the
pathogenesis of reperfusion injury [11]. Zhao et al.
recently found that infarction size increases significantly
between 6 h and 24 h after reperfusion in a canine
model. In agreement with this, the present study also
Figure 2 Myocardial infarction size at 2 and 24 hours after
reperfusion (n = 8 at each time point). Myocardial infarction size
was detected using TTC staining. Myocardial infarction area was
increased between 2 and 24 hours after reperfusion in all
intervention groups. PostC significantly reduced myocardial
infarction size after reperfusion. Both AG490 (a selective JAK2
inhibitor) and Wortmannin (a selective PI3K inhibitor) abolished
cardioprotection of PostC. *p < 0.05 compared with I/R-2 h and I/R-
24 h groups respectively; #p < 0.05 compared with I/R-2 h, PostC-2
h, PostC+AG490-2 h and PostC+wort-2 h groups respectively. IS =
Infarction size, LV = Left ventricle, AAR = Area at risk.
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longed reperfusion in rat hearts. Myocardial reperfusion
injury may increase with the duration of reperfusion.
However, Argaud et al. found that myocardial infarction
size had no difference between 4 h and 72 h after reper-
fusion in rabbit hearts. The difference in animal species
and the procedures to induce ischemia/reperfusion
injury are considered to be the reasons for these differ-
ent results [2,12,13].
PostC was first described by Johansen’s group in 2003
[14]. After that, the ability of PostC to protect myocar-
dium from I/R injury has been confirmed by several stu-
dies and in multiple species. PostC not only reduces
infarction size but also limits apoptosis after reperfusion.
Recent studies reported that PostC affords persistent
infarction size reduction after prolonged reperfusion in
both canine models and humans [2,3]. But they did not
distinguish whether this long-term cardioprotection was
a continued effect of the early phase or an independent
effect. The present results s u g g e s t e dt h a tP o s t Cc o u l d
limit myocardial apoptosis after reperfusion. Bcl-2 levels
were significantly up-regulated by PostC. Interestingly,
there was an increase in Bcl-2 levels between 2 and 24
hours after reperfusion in PostC groups. This indicated
that PostC may reduce myocardial apoptosis during pro-
longed reperfusion via up-regulated anti-apoptotic fac-
tors such as Bcl-2. Further study focus on other
apoptosis-associated proteins such as Bcl-x, BAD and
BAX may be helpful to define the long-term benefit of
PostC.
Figure 3 Myocardial apoptosis at 2 and 24 hours after reperfusion (n = 8 at each time point). Myocardial apoptosis was detected by
TUNEL staining. TUNEL-positive cells (black staining) increased during prolonged reperfusion. PostC significantly reduced myocardial apoptosisa t
both 2 and 24 hours after reperfusion. AG490 and Wortmannin attenuated the anti-apoptotic effects of PostC. *p < 0.05 compared with I/R-2 h
and I/R-24 h groups respectively; #p < 0.05 compared with I/R-2 h, PostC-2 h, PostC+AG490-2 h and PostC+wort-2 h groups respectively; &p <
0.05 compared with PostC-2 h and PostC-24 h respectively.
Tian et al. Journal of Biomedical Science 2011, 18:53
http://www.jbiomedsci.com/content/18/1/53
Page 5 of 8The anti-apoptotic effects of the JAK2-STAT3 signal-
ing pathway have been shown by several studies in
tumors. Several apoptosis-related protein genes, such as
Bcl-2 and Bcl-xl, have been identified as target genes of
STAT3 [15,16]. Many studies have demonstrated that
ischemic preconditioning upregulates COX-2 and iNOS
at 24 hours after intervention, which is dependent on
transcriptional regulation by the JAK-STAT pathway
[17,18]. The present results showed that PostC signifi-
cantly activated STAT3 after reperfusion and AG490
attenuated the anti-apoptotic effect of PostC. Elevation
of Bcl-2 after reperfusion required STAT3 activation
which indicated that PostC may afford a persistent anti-
apoptotic effect via a JAK2-STAT3-Bcl-2 pathway.
Activation of the PI3K/Akt pathway prevents cardiac
myocyte apoptosis and protects the myocardium from I/
R injury. Furthermore, as the major component of the
RISK (Reperfusion Injury Salvage Kinase) pathway, the
PI3K/Akt pathway has been shown to play a crucial role
in PostC [19-21]. Goodman et al.d e m o n s t r a t e dt h a t
JAK-STAT signaling may provide upstream initiation of
RISK pathway signaling via PI3K-Akt activation, and
JAK-STAT signaling is insufficient on its own to provide
cardioprotection following PostC without subsequent
RISK activation [7]. In accordance with this, the present
study showed that JAK2 signaling regulated the activa-
tion of the PI3K/Akt pathway in PostC. Blocking the
PI3K/Akt pathway attenuated the cardioprotection of
Figure 4 Protein levels myocardial Bcl-2 at 2 and 24 hours after reperfusion (n = 8 at each time point). Bcl-2 levels were detected by
immunohistochemical staining. PostC elevated Bcl-2 expression in myocardial (brown staining) at both 2 and 24 hours after reperfusion. AG490
abrogated the up-regulation of Bcl-2 levels by PostC. Wortmannin had no effects on Bcl-2 levels. *p < 0.05 compared with I/R-2 h and I/R-24 h
groups respectively; #p < 0.05 compared with PostC-2 h and PostC+wort-2 h groups respectively; $p < 0.05 compared with PostC-2 h and
PostC-24 h groups respectively.
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effect on Bcl-2 levels after PostC. The possible explana-
tion of these results is that activation of JAK2-STAT3-
Bcl-2 pathway alone may be not sufficient to limit apop-
tosis without activation of PI3K/Akt pathway.
Conclusions
In conclusion, the present study demonstrated that
PostC may reduce myocardial apoptosis during pro-
longed reperfusion via a JAK2-STAT3-Bcl-2 pathway.
As a downstream target of JAK2 signaling, the activation
of PI3K/Akt pathway may be necessary in the protection
of PostC. Time-course experiments in further study may
be helpful to demonstrate precise roles of the pathways
in prolonged protection of PostC. However, our results
indicated that the protective effect of PostC is not
enough to prevent myocardial apoptosis during pro-
longed reperfusion. Combination therapy targeting
apoptosis during prolonged reperfusion may provide
more effective protection.
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